Risk/Benefit Tradeoff of Antithrombotic Therapy in Patients With Atrial Fibrillation Early and Late After an Acute Coronary Syndrome or Percutaneous Coronary Intervention

Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation

(2019) Renato D. Lopes et al.   NEW ENGLAND JOURNAL OF MEDICINE

2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

(2019) Craig T. January et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Safety and Efficacy of Antithrombotic Strategies in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention

(2019) Renato D. Lopes et al.   JAMA Cardiology

Hospitalization among Patients with Atrial Fibrillation and a Recent Acute Coronary Syndrome or Percutaneous Coronary Intervention Treated with Apixaban or Aspirin: Insights from the AUGUSTUS Trial

(2019) Amit N. Vora et al.   CIRCULATION

Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or with Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights from the AUGUSTUS Trial

(2019) Stephan Windecker et al.   CIRCULATION

Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial

(2019) Pascal Vranckx et al.   LANCET

Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease

(2019) Satoshi Yasuda et al.   NEW ENGLAND JOURNAL OF MEDICINE

Stent Thrombosis in Patients with Atrial Fibrillation Undergoing Coronary Stenting in the AUGUSTUS Trial

(2019) Renato D. Lopes et al.   CIRCULATION

Antithrombotic therapy after acute coronary syndrome and/or percutaneous coronary intervention in atrial fibrillation: finding the sweet spot

(2019) Renato D Lopes et al.   EUROPEAN HEART JOURNAL

An open-Label, 2 × 2 factorial, randomized controlled trial to evaluate the safety of apixaban vs. vitamin K antagonist and aspirin vs. placebo in patients with atrial fibrillation and acute coronary syndrome and/or percutaneous coronary intervention: Rationale and design of the AUGUSTUS trial

(2018) Renato D. Lopes et al.   AMERICAN HEART JOURNAL

Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention

(2018) Dominick J. Angiolillo et al.   CIRCULATION

Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation

(2017) Christopher P. Cannon et al.   NEW ENGLAND JOURNAL OF MEDICINE

Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease

(2016) Renato D. Lopes et al.   AMERICAN JOURNAL OF MEDICINE

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

(2016) Paulus Kirchhof et al.   EUROPEAN HEART JOURNAL

Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI

(2016) C. Michael Gibson et al.   NEW ENGLAND JOURNAL OF MEDICINE

2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction

(2015) Glenn N. Levine et al.   CIRCULATION

2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes

(2014) Ezra A. Amsterdam et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Apixaban versus warfarin in patients with atrial fibrillation according to prior warfarin use: Results from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial

(2013) David A. Garcia et al.   AMERICAN HEART JOURNAL

Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial

(2013) Willem JM Dewilde et al.   LANCET

2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction

(2012) Patrick T. O'Gara et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Apixaban in Patients with Atrial Fibrillation

(2011) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Apixaban versus Warfarin in Patients with Atrial Fibrillation

(2011) Christopher B. Granger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Risk of Bleeding With Single, Dual, or Triple Therapy With Warfarin, Aspirin, and Clopidogrel in Patients With Atrial Fibrillation

(2010) Morten L. Hansen et al.   ARCHIVES OF INTERNAL MEDICINE

Triple antithrombotic management after stent implantation: when and how?

(2009) A. Schomig et al.   HEART

Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data

(2009) Rikke Sørensen et al.   LANCET